News
Broad access to the fruits of NIH’s investments—whether in the form of data, results, or products—drives innovation. To advance this aim, NIH is launching a new policy to improve access to medical products developed from NIH-owned inventions. This policy emphasizes the importance of proactive
The NIH National Institute of Allergy and Infectious Diseases (NIAID) has won the USPTO Patents for Humanity: COVID-19 Award. This award was given to five organizations for their rapid response to the COVID-19 pandemic through the use of technologies. NIAID, in collaboration with the Scripps
Dr. Tom Stackhouse, Director of the National Cancer Institute (NCI)’s Technology Transfer Office, will be giving a webinar on Cooperative R&D Agreements, otherwise known as CRADAs. This free event, put on by The Center for Advancing Innovation is a great opportunity for anyone looking to advance an
If you are interested in collaborating on an oncology-related technology, don’t miss the National Cancer Institute’s (NCI) Michael Salgaller and the Office of Technology Transfer’s (OTT) Steven Ferguson’s presentation at the MedInvest Oncology Investor Conference from December 14-15, 2022. This